- Report
- February 2021
- 500 Pages
United States
From €2306EUR$2,400USD£1,980GBP
- Report
- August 2020
- 250 Pages
Saudi Arabia
From €3459EUR$3,600USD£2,969GBP
- Report
- February 2024
- 70 Pages
Saudi Arabia
From €4564EUR$4,750USD£3,918GBP
- Report
- October 2019
- 125 Pages
Canada
From €4564EUR$4,750USD£3,918GBP
Glyburide is a drug used to treat type 2 diabetes, a condition in which the body does not produce enough insulin or does not use insulin properly. It belongs to a class of drugs known as sulfonylureas, which work by stimulating the pancreas to produce more insulin. Glyburide is used to help control blood sugar levels in people with type 2 diabetes. It is usually taken once or twice a day with meals.
Glyburide is a widely used drug in the Endocrine and Metabolic Disorders Drugs market. It is used to treat type 2 diabetes, a condition that affects millions of people worldwide. It is a cost-effective and well-tolerated drug, making it a popular choice for many patients. It is also available in generic form, which further reduces the cost of treatment.
Some companies in the Glyburide market include Merck & Co., Inc., Sanofi, Novo Nordisk, and Eli Lilly and Company. Show Less Read more